In a population-based case-control study in Sweden on multiple myeloma, the occurrence of different diseases in relatives, particularly hematologic malignancies and different types of cancer, was investigated. Through a questionnaire mailed to all living subjects, i.e. cases and controls, and to the next-of-kin for deceased subjects, information was obtained on malignant and certain other diseases among relatives. All malignant diseases reported among first-degree relatives were verified, if possible, through parochial authorities and the Swedish Cancer Register. In total, data from 239 cases with myeloma and 220 controls were analyzed. An increased risk was found for persons with first-degree relatives with hematologic malignancies (relative risk [RR]=2.36, 90 percent confidence interval [CI]=0.90–6.15), and also with multiple myeloma specifically (RR=5.64, CI=1.16–27.51). An increased risk also was seen if the close relatives had experienced another tumor disease (RR=1.21, CI=0.86–1.71). Particularly, occurrence of prostatic cancer (RR=3.11, CI=1.25–7.71) or brain tumor (RR=6.61, CI=1.42–30.67) in relatives increased the risk for multiple myeloma.
Similar content being viewed by others
References
Meyerding HW. Multiple myeloma. Radiology 1925; 5: 132–6.
Geschickter CF, Copeland MM. Multiple myeloma. Arch Surg 1928; 16: 807–63.
Mandema E, Wildervanck LS. La maladie de Kahler (myelomes multiples) chez deux soeurs. J. Genet Hum 1954; 3: 170–5.
Shoenfeld Y, Berliner S, Shaklai M, Gallant LA, Pinkhas J. Familial multiple myeloma. A review of thirty-seven families. Postgrad Med J 1982; 58: 12–6.
Isobe T, Shaura K, Itoh T, Fujita T. Myeloma in siblings. Acta Haematol Jpn 1981; 44: 98–101.
Hubert D, Thomas M, Krulik M, et al. Myelome familial: A propos d'un cas. Rev Med Interne 1985; 5: 447–52.
Judson IR, Wiltshaw E, Newland AC. Multiple myeloma in a pair of monozygotic twins: the first reported case. Br J Haematol 1985; 60: 551–4.
Horwitz LJ, Levy RN, Rosner F. Multiple myeloma in three siblings. Arch Intern Med 1985; 145: 1449–50.
McCrea AP, Morris TCM. Concurrent familial myeloma in Northern Ireland. Cancer 1986; 58: 394–6.
Grosbois B, Gueguen M, Fauchet R, et al. Multiple myeloma in two brothers. An immunochemical and immunogenetic familial study. Cancer 1986; 58: 2417–21.
Eriksson M, Bergström I. Familial malignant blood disease in the county of Jämtland, Sweden. Eur J Haematol 1987; 38: 241–5.
Wirtschafter SK, Rapaport SI. The familial occurrence of chronic lymphocytic leukemia and multiple myeloma. California Med 1960; 92: 165–6.
Kyle RA, Henderson ES, Randolph VL, Budge WR. Multiple myeloma, acute leukemia and Hodgkin's disease: Occurrence in three of four family members. Cancer 1976; 37: 1496–9.
Bourguet CC, Grufferman S, Delzell E, DeLong ER, Cohen HJ. Multiple myeloma and family history of cancer. A case-control study. Cancer 1985; 56: 2133–9.
Grufferman S, Cohen HJ, Delzell ES, Morrison MC, Schold SC, Moore JO. Familial aggregation of multiple myeloma and central nervous system diseases. J Am Geriatr Soc 1989; 37: 303–9.
Linet MS, McLaughlin JK, Harlow SD, Fraumeni JFJr. Family history of autoimmune disorders and cancer in multiple myeloma. Int J Epidemiol 1988; 17: 512–3.
Committee of the chronic leukemia-myeloma task force, NCI. Proposed guidelines for protocol studies. II. Plasma cell myeloma. Cancer Chemother Rep 1968; 1: 17–39.
Miettinen OS. Estimation of relative risk from individually matched series. Biometrics 1970; 26: 75–86.
Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976; 103: 226–35.
Additional information
Dr Eriksson in with the Department of Oncology, University Hospital, S-901-85 Umeå, Sweden. Dr Hållberg is with the Department of Statistics, Umeå University, Umeå, Sweden. Address correspondence to Dr Eriksson. This research was supported by grants from the Swedish Cancer Fund. (Project 2683-B90-02X.)
Rights and permissions
About this article
Cite this article
Eriksson, M., Hållberg, B. Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study. Cancer Causes Control 3, 63–67 (1992). https://doi.org/10.1007/BF00051914
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00051914